Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer.
Zhenchao ZhangRui LuoWilliam K KellyJoshua ChenShane DonahueKevan IpNathan R HandleyWilliam J TesterMiranda L TsangFelix J KimRonald MyersGrace Lu-YaoJian GuJianqing LinBingshan LiChun WangHushan YangPublished in: Prostate cancer and prostatic diseases (2023)
Our study provides the first evidence to support the potential of prostein expression on CTCs to serve as a novel prognostic marker in mCRPC patients. Future large-scale prospective studies are needed to validate our findings.
Keyphrases
- circulating tumor cells
- poor prognosis
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- small cell lung cancer
- squamous cell carcinoma
- circulating tumor
- peritoneal dialysis
- prognostic factors
- binding protein
- current status
- patient reported outcomes
- climate change
- risk assessment
- patient reported